Related Experiment Video
Updated: Nov 16, 2025

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Low blood sugar levels in the newborn infant: Do changing goal posts matter?
1Division of Neonatal Medicine, Department of Pediatrics, University of Louisville School of Medicine, 571 South Floyd Street, Suite 342, Louisville, Kentucky, 40202-3830, USA.
Insights
Neonatal hypoglycemia and hyperglycemia impact fetal and newborn brain development. This review contrasts guidelines on defining neonatal hypoglycemia, exploring evidence-based practices, pathogenesis, and management strategies.
Area of Science:
- Neonatal medicine
- Pediatric endocrinology
- Metabolic disorders
Background:
- Glucose is vital for fetal and newborn growth and brain development.
- Disruptions in glucose metabolism lead to hypoglycemia or hyperglycemia.
- Current practices for defining neonatal hypoglycemia vary.
Purpose of the Study:
- To contrast American Academy of Pediatrics and Pediatric Endocrine Society guidelines on neonatal hypoglycemia.
- To review recent studies contributing to the controversy in defining neonatal hypoglycemia.
- To discuss evidence-based guidelines, pathogenesis, outcomes, and management of neonatal glucose disorders.
Main Methods:
- Literature review of recent studies and existing guidelines.
- Comparative analysis of recommendations from major pediatric societies.
- Synthesis of evidence on definitions, pathogenesis, and management.
Main Results:
- Contrasting definitions of neonatal hypoglycemia exist between major pediatric organizations.
- Recent research adds complexity to the ongoing debate on hypoglycemia thresholds.
- Variations in clinical practices are evident.
Conclusions:
- A unified definition and approach to neonatal hypoglycemia are needed.
- Further research and trials are necessary to establish optimal management strategies.
- Evidence-based guidelines are crucial for improving neonatal outcomes.
Abstract:
Glucose supply and metabolism are essential for growth and normal brain development in both the fetus and newborn. Disorders of glucose availability and metabolism can result in either hypoglycemia or hyperglycemia. The first section of this manuscript will contrast recommendations from the American Academy of Pediatrics and the Pediatric Endocrine Society on the approach to defining neonatal hypoglycemia. Recent studies will be reviewed which add to the controversy. This review aims to discuss the evidence-based guidelines, definitions, pathogenesis, outcomes and management options in this field. The current variations in practices and possibilities of future trials are also addressed.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Pharmacokinetics in Pediatric Patients: Drug Distribution
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

